| TARGET | |
|---|---|
| SYNONYMS |
M3S1; TAAL6 |
| DESCRIPTION |
Human TM4SF1 full length protein membrane nanoparticles (MNPs) |
| DELIVERY |
In Stock |
| UNIPROT ID |
P30408 |
| EXPRESSION HOST |
HEK293 |
| PROTEIN FAMILIES |
Transmembrane |
| PROTEIN PATHWAYS |
—— |
| MOLECULAR WEIGHT |
The human full length TM4SF1 protein has a MW of 21.6 kDa |
| FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| BACKGROUND |
The protein is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface antigen and is highly expressed in different carcinomas. |
| USAGE |
Research use only |
Dima Biotech
SKU(재고 관리 코드):FLP100021
Human TM4SF1 full length protein-MNP
Human TM4SF1 full length protein-MNP
PRODUCT DATA
IMAGES
Figure1. Elisa plates were pre-coated with 0.5μg/per well purified human TM4SF1 full length membrane nanoparticles. Serial diluted anti-TM4SF1 monoclonal antibody (BME100159) solutions were added, washed, and incubated with secondary antibody before Elisa reading. From above data, the EC50 for anti-TM4SF1 monoclonal antibody binding with TM4SF1 full length membrane nanoparticles is 4.174ng/ml.
Figure2. FACS analysis of TM4SF1 MNPs
A. Negative Control 1: TM4SF1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody.
B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-TM4SF1 antibody (BME100159) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
C. Negative Control 3: TM4SF1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
D. TM4SF1 full length membrane nanoparticles samples were stained with anti-TM4SF1 antibody (BME100159) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
